PMID- 31945095 OWN - NLM STAT- MEDLINE DCOM- 20200420 LR - 20200420 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 15 IP - 1 DP - 2020 TI - Obesity, smoking habits, and serum phosphate levels predicts mortality after life-style intervention. PG - e0227692 LID - 10.1371/journal.pone.0227692 [doi] LID - e0227692 AB - BACKGROUND: Life-style interventions, including smoking cessation and weight control are of importance for managing future escalating prevalence of obesity. Smoking habits and obesity have jointly great impact on mortality, however mechanisms behind the effect and variables involved in the obesity paradox is still unknown. OBJECTIVES: This study examines risk factors for all-cause, cardiovascular, and cancer mortality in males and females with high cardiovascular risk, mediated by smoking habits, body mass index (BMI, kg/m2), and serum phosphate (S-P) levels. METHODS: Patients were admitted to the Vindeln Patient Education Center in groups of 30 for a four-week residential comprehensive program (114 hours) focusing on smoking cessation, stress reduction, food preferences and selections, and physical exercise. The follow-up, in years from 1984 to 2014 corresponds to 30 years. This study included 2,504 patients (1,408 females and 1,096 males). Cox regression analysis was used to assess mortality risk associated with smoking habits, low and high BMI, and low and high S-P levels. RESULTS: High BMI (>34,2 kg/m2), current smoking, type 2 diabetes mellitus (T2DM), high serum calcium (S-Ca), mmol/L and high systolic blood pressure (SBP, mmHg) were associated with all-cause mortality irrespective of sex. Former and current smoking females had a high all-cause mortality (adjusted hazard ratio [HR] 1.581; 95% CI 1.108-2.256, adjusted hazard ratio [HR] 1.935; 95% CI 1.461-2.562, respectively) while current smoking and high BMI increased risk for cardiovascular mortality (adjusted hazard ratio [HR] 3.505; 95% CI 2.140-5.740 and [HR] 1.536; 95% CI 1.058-2.231, respectively). Neither low nor high levels of S-P predicted all-cause, cardiovascular disease (CVD) and cancer mortality in males or females while low levels of S-P predicted all-cause mortality in smokers (adjusted hazard ratio [HR] 1.713; 95% CI 1.211-2.424). In non-smokers, low BMI (<27.6 kg/m2) was protecting and high BMI a risk for all-cause mortality. In males, ischemic heart disease (IHD), and low serum albumin (S-Alb) were associated with all-cause mortality. In females, an interaction between high BMI and smoking (HbmiSM) decreased the cardiovascular mortality (adjusted hazard ratio [HR] 0.410; 95% CI 0.179-0.937, respectively). CONCLUSIONS: High BMI and current smoking were associated with all-cause mortality in both males and females in the present high cardiovascular-risk cohort. In current smokers and non-smokers, T2DM and high S-Ca were associated with an increase in all-cause mortality, while low S-P was associated with all-cause mortality in smokers. Interaction between high BMI and smoking contribute to the obesity paradox by being protective for cardiovascular mortality in females. FAU - Haglin, Lena AU - Haglin L AUID- ORCID: 0000-0001-6526-7417 AD - Department of Public Health and Clinical Medicine, Family Medicine, Umea University, Umea, Sweden. FAU - Tornkvist, Birgitta AU - Tornkvist B AD - Department of Public Health and Clinical Medicine, Family Medicine, Umea University, Umea, Sweden. FAU - Backman, Lennart AU - Backman L AD - Department of Public Health and Clinical Medicine, Family Medicine, Umea University, Umea, Sweden. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200116 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Phosphates) SB - IM MH - Adult MH - Body Mass Index MH - Cohort Studies MH - Female MH - Health Promotion/*methods MH - Healthy Lifestyle MH - Humans MH - Male MH - Middle Aged MH - Obesity/blood/*mortality/therapy MH - Phosphates/*blood MH - Risk Factors MH - Smoking/blood/*mortality/therapy MH - Smoking Cessation MH - Sweden/epidemiology MH - Weight Reduction Programs PMC - PMC6964906 COIS- The authors have declared that no competing interests exist. EDAT- 2020/01/17 06:00 MHDA- 2020/04/21 06:00 PMCR- 2020/01/16 CRDT- 2020/01/17 06:00 PHST- 2019/02/12 00:00 [received] PHST- 2019/12/23 00:00 [accepted] PHST- 2020/01/17 06:00 [entrez] PHST- 2020/01/17 06:00 [pubmed] PHST- 2020/04/21 06:00 [medline] PHST- 2020/01/16 00:00 [pmc-release] AID - PONE-D-19-04197 [pii] AID - 10.1371/journal.pone.0227692 [doi] PST - epublish SO - PLoS One. 2020 Jan 16;15(1):e0227692. doi: 10.1371/journal.pone.0227692. eCollection 2020.